Clinical Trial Update: Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial of bazedoxifene/conjugated estrogen tablets in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Bazedoxifene/conjugated estrogen tablets (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Menopause | Phase 1 | Status: COMPLETED